Chief Executive Officer of Cupron, Inc., a US based Life Sciences polymer technology firm with patented processes and products in the medical, industrial and branded consumer verticals. Particular success in assembling and managing specialized scientific, product and sales talent for commercializing innovations in the material science arena. In response to COVID 19 pandemic, our Cupron team developed permanent anti-viral / anti-bacterial / anti-fungal self-sanitizing surfaces for a wide range of industries and uses. These applications are now recognized as a new category of anti-microbial solution that enjoy highly differentiated Public Health Claim performance and recognition from US health and safety regulators. Experienced in new product strategy & definition, US medical and consumer marketing, regulatory mapping / execution, operational scale-up and new product market introduction. CEO, Chairman of Board and Board Member experience with technology start-ups internationally.Previously, executive with 25+ years of Board / CEO / COO experience in transforming under-performing companies domestically and internationally. Experienced in developing and executing organic and inorganic growth strategies and radical cost reduction efforts. Successful in evaluating leadership team capabilities and implementing changes required for successful turnarounds. Knowledgeable of leveraging formal bankruptcy process as part of restructuring strategy.Notable accomplishments: -Creating and leading teams of driven, goal-oriented doers who have fun making something from nothing. -Institutionalizing technology-enabled process improvement for category leadership. -Restructuring mandates for private equity (PE and venture capital) owners of small to mid-cap portfolio companies struggling with either sub-standard historical performance or imminent bankruptcy prospects. -Driving new product strategy and execution for material science innovation technology. -Blending patent, trade secret, regulatory, contract and brand positioning to create lasting commercial value ... and then assembling the team that does it.